Oh I whole-heartedly agree with you there mopar, but instead of attempting to grow sales MNK just informed the market that not only are they still trying to sell their generics division, they're planning on reporting their generics as "ceased operations" moving fwd.
It's mind boggling how they've flubbed their generics sale attempt so badly over the past calendar year to the point that there's presently no suitors.
Another in a long line of baffling unforeseen negatives that IPCI seems to have found themselves stuck in sigh!
News 
Market Data 
Discover 
